IFNA1 and neutropenia: Neutropenia (13/26, 50%), abnormalities in thyroid function parameters (13/26, 50%) and ALT flares (11/26, 42.31%) were the most common adverse effects in the peg-IFN group, but all were transient without subjective symptoms.